Highlights of Clinical Trial Management Systems Market
- Clinical trial management systems market to surpass US$ 1 Bn during the review period
- Incremental opportunity of US$ 116 Mn in web-based clinical trial management systems market
- U.S. and EU5 among the most lucrative markets globally for vendors
Web-based clinical trial management systems continue to be the preferred mode of deployment for pharmaceutical and biotechnology companies, finds a new study by Fact.MR. The report projects that web-based clinical trial management systems will remain pervasive in the clinical trial management systems marketduring the review period 2018-2028, gaining an impressive US$ 116 Mn in incremental opportunity in a decade.
Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=832
Clinical Trial Management Systems Market to Surpass US$ 1 Billion During the Course of Forecast Period
The report is bullish on the prospects of clinical trial management systems market, and expects revenues to surpass US$ 1 billion during the course of the forecast period. Growth will be induced by a range of macroeconomic and industry-specific factors, with growing awareness on the critical role of clinical trial management systems in improving workflow influencing investment.
Clinical Trial Management Systems Market: Sensitization on Benefits over Paper-based Driving Growth
The report finds that sensitization about the operational benefits of clinical trial management system over manual paper-based process has been a key factor for increased adoption. While a majority of end-users are using clinical trial management systems in-house, a significant percentage of end-users also outsource to vendors, such as CROs and SMOs. Outsourcing of site monitoring, site management, and schedule tracking functions was highest among end-users.
Browse Full Report @ https://www.factmr.com/report/832/clinical-trial-management-systems-market
According to the report, standardization, SaaS-based solutions, and flexibility in terms of pricing and licensing are among the key evolutions in the clinical trial management system market. The increasing complexity in clinical trials has meant that pharmaceutical companies prefer outsourcing clinical trial execution to contract organizations. Outsourcing is likely to gain further momentum during the assessment period as proliferation of specialty clinical research organizations and academic research organizations (AROs) witnesses a spike.
The report finds that revenues generated from clinical trial management software are higher than services, and the status quo is unlikely to remain unchanged during the assessment period. The revenues generated from clinical trial management software is nearly 3x of services in 2018, and both these segments are likely to grow at similar CAGR during the assessment period.
Preference for enterprise-based clinical trial management systems is higher among end-users. The preference for enterprise-based clinical trial management systems can be gauged by the fact that this segment accounted for nearly three-fourth revenue share of the market in 2018. The preference for enterprise-based clinical trials is likely to continue unabated during the review period.
You can Buy This Report from Here @ https://www.factmr.com/checkout/832/S
Adoption of clinical trial management systems is mainly concentrated among pharmaceutical companies, contract research organizations (CROs), and healthcare providers. Pharmaceutical companies account for nearly three-fourth revenue share of the clinical trial management systems market, with healthcare providers accounting for a miniscule revenue share.
The penetration rate of clinical trial management systems is higher in the US and EU5, with pharmaceutical companies and other end-users adopting a proactive approach towards adoption of advanced software and services. The proliferation of clinical trial management systems in the US is reflected by the statistic that the country accounts for nearly 40% revenue share of the global clinical trial management systems market. The adoption rate is also impressive in Canada, albeit the market is likely to grow from a small base.
According to the report, adoption of clinical trial management systems in Europe is concentrated in Germany, U.K., Spain, Italy, and France. These five markets collectively account for nearly 68% revenue share of the clinical trial management systems market. Germany is likely to retain its position as the most lucrative market for clinical trial management systems, whereas growth is likely to be sluggish in the U.K.
Table of Contents Covered in this report are:
Chapter 1 Executive Summary
Chapter 2 Global Clinical Trial Management Systems Market Overview
2.2 Market Definition
2.3 Scope of the report
Chapter 3 Market Dynamics
3.1 Key Growth Drivers
3.1.1 The Role of CTMS in Improving Workflow
3.1.2 Importance in the eClinical Framework
3.1.3 Growing Importance of CTMS in eClinical Value Chain
3.1.4 Streamlining Research Activities
3.2 Key Market Restraints
3.2.1 Evolving Roadblocks
3.2.2 Complex Trial Management
3.3.1 Progress in Web Technology
3.3.2 Increasing Biomedical Research Funding
3.3.3 Key Trends
3.3.4 Increasing Outsourcing Activities
3.3.5 Growing Focus on Price and Modularity
3.3.6 List of Key CTMS Software
3.4 CTMS Process Chain
3.4.1 Investment Feasibility Analysis for CTMS
3.5 Market White Space and Wheel of Fortune Analysis
3.6 Product Life Cycle Analysis
3.7 Porter’s Five Forces Analysis
3.8 PESTLE Analysis
Chapter 4 Global Clinical Trial Management Systems Market Analysis
4.1 Global Market Outlook
4.1.1 Market Forecast and Analysis
4.1.2 Regional Demand Assessment
184.108.40.206 Market Share by Region
4.2 Global CTMS Market Analysis by Mode of Deployment
4.2.1 Forecast by Mode of Deployment
4.2.2 Y-o-Y Growth Comparison by Mode of Deployment
4.2.3 Market Attractiveness Analysis by Mode of Deployment
4.3 Global CTMS Market Analysis by Component
4.3.1 Forecast by Component
4.3.2 Y-o-Y Growth Comparison by Component
4.3.3 Market Attractiveness Analysis by Component
4.4 Global CTMS Market Analysis by Product Type
4.4.1 Forecast by Product Type
4.4.2 Y-o-Y Growth Comparison by Product Type
4.4.3 Market Attractiveness Analysis by Product Type
4.5 Global CTMS Market Analysis by End-user
4.5.1 Forecast by End-user
4.5.2 Y-o-Y Growth Comparison by End-user
4.5.3 Market Attractiveness Analysis by End-user